| Ticker Details |
ADMA Biologics Inc
ADMA Biologics Inc is a biopharmaceutical company. The company develops and manufactures specialty plasma-based biologics for the proposed treatment of immune deficiencies and prevention of certain infectious diseases.
|
| IPO Date: |
October 18, 2013 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$1.85B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.18 | 3.03%
|
| Avg Daily Range (30 D): |
$0.28 | 3.02%
|
| Avg Daily Range (90 D): |
$0.39 | 3.20%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
1.59M |
| Avg Daily Volume (30 D): |
4.86M |
| Avg Daily Volume (90 D): |
4.82M |
| Trade Size |
| Avg Trade Size (Sh.): |
171 |
| Avg Trade Size (Sh.) (30 D): |
129 |
| Avg Trade Size (Sh.) (90 D): |
115 |
| Institutional Trades |
| Total Institutional Trades: |
2,382 |
| Avg Institutional Trade: |
$3.46M |
| Avg Institutional Trade (30 D): |
$2.73M |
| Avg Institutional Trade (90 D): |
$3.79M |
| Avg Institutional Trade Volume: |
.31M |
| Avg Institutional Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$5.89M |
| Avg Closing Trade (30 D): |
$6.43M |
| Avg Closing Trade (90 D): |
$8.57M |
| Avg Closing Volume: |
523.66K |
|
|
| Financials |
| |
TTM |
Q1 2026 |
Q4 2025 |
|
Basic EPS
|
$.69
|
$.19
|
$.21
|
|
Diluted EPS
|
$.68
|
$.19
|
$.2
|
|
Revenue
|
$509.86M
|
$114.49M
|
$139.16M
|
|
Gross Profit
|
$312.42M
|
$80.75M
|
$88.82M
|
|
Net Income / Loss
|
$165.35M
|
$45.33M
|
$49.38M
|
|
Operating Income / Loss
|
$214.84M
|
$58.27M
|
$62.75M
|
|
Cost of Revenue
|
$197.45M
|
$33.74M
|
$50.35M
|
|
Net Cash Flow
|
$66.53M
|
$50.52M
|
$26.25M
|
|
PE Ratio
|
|
|
|
|
|
|
